FDA.reportPublic FDA data

Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT per 1 ML Injection

RxCUI
2624746
RxNorm name
Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT per 1 ML Injection
Display name
Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT per 1 ML Injection
Full name
Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT per 1 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125690ErveboEbola Zaire Vaccine, Live351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2b1db7a1-c3f2-42e5-8499-91724edbf65eZaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT in 1 ML Injection [PSN] · 1 ML Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML Injection [SCD] · Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT per 1 ML Injection [SY]316These highlights do not include all the information needed to use ERVEBO safely and effectively. See full prescribing information for ERVEBO. ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection Initial U.S. Approval: 201920250131